The Ballito community has rallied behind parents Ryan and Nicky Walsh after the couple were both diagnosed with cancer in the ...

DelveInsight's“ Triple Negative Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 165+ ...

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.

Agenus shareholders have suffered a modest ~13% loss since my last analysis, based on cash flow challenges and lack of near ...

Five years ago when Rachelle Vance heard the diagnosis “triple negative breast cancer,” she decided she didn’t want to be just a survivor.

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced the first patient dosing in the U.S. for a clinical study of its novel nectin-4-targeting ...

A phase 1/2 trial reveals sacituzumab tirumotecan shows manageable toxicity and promising antitumor activity in patients with ...

When people hear breast cancer, they often picture women in their 50s or 60s. While the majority of cases occur after 40, a growing number of younger women are hearing those same three words: “You ...

Melissa Louise Pilewskie, MD, clinical associate professor in the department of surgery and co-director of the Weiser Family Center for Breast Cancer at Michigan Medicine, discusses treatment options ...

This report details how pleomorphic breast carcinoma evaded initial treatment protocols and spread to 70% of the thorax ...

In an experiment involving 32 breast cancer survivors, a 45-minute session of either resistance training or high-intensity ...

An anti-nausea drug may reduce recurrence and death in aggressive breast cancer. Scientists are exploring its broader use in ...